SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-101547
Filing Date
2023-04-14
Accepted
2023-04-14 09:57:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d501096ddefa14a.htm DEFA14A 18518
2 GRAPHIC g501096g0414082919566.jpg GRAPHIC 3378
  Complete submission text file 0001193125-23-101547.txt   24272
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36352 | Film No.: 23820024
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences